North America Viral Inactivation Market is poised to reach USD 282.06 million by 2023
North America Viral Inactivation Market By Method (Solvent/Detergent Method, Pasteurisation, UV Radiation, Microwave Heating And High-Energy Light)
(EMAILWIRE.COM, July 25, 2018 ) North America Viral Inactivation Market was worth USD 152.42 million in 2018 and estimated to be growing at a CAGR of 13.1%, to reach USD 282.06 million by 2023.
Rise in the number of pharmaceutical and biopharmaceutical companies, increasing investment in the life sciences sector, rise in the number of drug launches & approvals, increase in funding by government for the development of pharmaceutical and biopharmaceutical industries are some of the major factors propelling growth of the market.
View Full Report @ https://marketdataforecast.com/market-reports/north-america-viral-inactivation-market-3230/
In the recent years, a huge number of companies and other government bodies have invested heavily for the development of the life sciences segment. This has led to an overall increase in the number of new and alternative therapies for the treatment of diseases, such as stem cell therapy and cellular & gene therapy. Viral inactivation is a crucial process that is mandatory in the production of these products to prevent contamination and prevent any fatalities after human consumption.
Download Free Sample of the report @ https://marketdataforecast.com/market-reports/north-america-viral-inactivation-market-3230/request-sample
Product Insights:
Based on product the market is divided into services, kits and reagents, accessories and viral inactivation systems. With respect to application, the market is fragmented into vaccines and therapeutics, stem cell products, cell culture, gene therapy and blood & blood products. Vaccines and therapeutics has the largest share in this segment.
Customized Research report @ https://marketdataforecast.com/market-reports/north-america-viral-inactivation-market-3230/customize-report
Application Insights:
Based on application, the viral inactivation market is segmented into vaccines & therapeutics, stem cell products, blood & blood tissue products, tissue & tissue products, and cellular & gene therapy products. Vaccines & therapeutics is expected to grow at the fastest rate due to growth in biologics production and increase in government funding for the promotion of usage of biologics to treat diseases.
Competitive Landscape
Some of the major players in the market include Clean Cells, Charles River Laboratories International Inc, Danaher Corporation, Merck KGaA, Parker Hannifin, Red Source Technologies, Sartorius AG, SGS S.A, Texcell Inc, Viral Inactivated Plasma Systems SA, and WuXi Pharma Tech Inc.
Rise in the number of pharmaceutical and biopharmaceutical companies, increasing investment in the life sciences sector, rise in the number of drug launches & approvals, increase in funding by government for the development of pharmaceutical and biopharmaceutical industries are some of the major factors propelling growth of the market.
View Full Report @ https://marketdataforecast.com/market-reports/north-america-viral-inactivation-market-3230/
In the recent years, a huge number of companies and other government bodies have invested heavily for the development of the life sciences segment. This has led to an overall increase in the number of new and alternative therapies for the treatment of diseases, such as stem cell therapy and cellular & gene therapy. Viral inactivation is a crucial process that is mandatory in the production of these products to prevent contamination and prevent any fatalities after human consumption.
Download Free Sample of the report @ https://marketdataforecast.com/market-reports/north-america-viral-inactivation-market-3230/request-sample
Product Insights:
Based on product the market is divided into services, kits and reagents, accessories and viral inactivation systems. With respect to application, the market is fragmented into vaccines and therapeutics, stem cell products, cell culture, gene therapy and blood & blood products. Vaccines and therapeutics has the largest share in this segment.
Customized Research report @ https://marketdataforecast.com/market-reports/north-america-viral-inactivation-market-3230/customize-report
Application Insights:
Based on application, the viral inactivation market is segmented into vaccines & therapeutics, stem cell products, blood & blood tissue products, tissue & tissue products, and cellular & gene therapy products. Vaccines & therapeutics is expected to grow at the fastest rate due to growth in biologics production and increase in government funding for the promotion of usage of biologics to treat diseases.
Competitive Landscape
Some of the major players in the market include Clean Cells, Charles River Laboratories International Inc, Danaher Corporation, Merck KGaA, Parker Hannifin, Red Source Technologies, Sartorius AG, SGS S.A, Texcell Inc, Viral Inactivated Plasma Systems SA, and WuXi Pharma Tech Inc.
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results